Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Enhancing Tregs can protect against alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Targeting specific T cells may help treat alopecia areata.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

CD34 is crucial for skin tumor development in mice.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.